NOVEL SYNTHETIC AGONISTS OF TLR9

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110293565A1
SERIAL NO

12695883

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to synthetic chemical compositions that are useful for modulation of Toll-Like Receptor (TLR)-mediated immune responses. In particular, the invention relates to agonists of Toll-Like Receptor 9 (TLR9) that generate unique cytokine and chemokine profiles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IDERA PHARMACEUTICALS INC167 SIDNEY STREET CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Agrawal, Sudhir Shrewsbury, US 223 8509
Bhagat, Lakshmi Framingham, US 54 1124
Kandimalla, Ekambar Southboro, US 59 812
Putta, Mallikarjuna Burlington, US 20 174
Wang, Daqing Bedford, US 91 766
Yu, Dong Westboro, US 354 6818

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation